Interestingly, the higher serum ObR levels were found in cats with mammary carcinomas presenting a HER2-positive/ER-negative status (p = 0.0291), as reported for human breast cancer patients (14), confirming the crosstalk between the leptin/ObR axis and the EGFR downstream signaling pathway (65). This evidence concerns the gene EGFR and breast cancer.